PMC:7443692 / 259-514 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T5","span":{"begin":231,"end":236},"obj":"Species"}],"attributes":[{"id":"A5","pred":"ncbi_taxonomy_id","subj":"T5","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T4","span":{"begin":40,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T104","span":{"begin":237,"end":241},"obj":"Protein"}],"attributes":[{"id":"A104","pred":"uniprot_id","subj":"T104","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T3","span":{"begin":23,"end":27},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"},{"id":"T4","span":{"begin":28,"end":32},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T5","span":{"begin":103,"end":107},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T5","span":{"begin":28,"end":32},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T1","span":{"begin":139,"end":152},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T1","span":{"begin":139,"end":152},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T10","span":{"begin":28,"end":32},"obj":"GO:0035376"},{"id":"T11","span":{"begin":71,"end":86},"obj":"CHEBI:17089;CHEBI:17089"},{"id":"T12","span":{"begin":192,"end":201},"obj":"CHEBI:60816;CHEBI:60816"},{"id":"T13","span":{"begin":231,"end":236},"obj":"SP_6;NCBITaxon:9606;PG_10"},{"id":"T14","span":{"begin":237,"end":241},"obj":"PG_10;PR:000003622"}],"text":"protein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined "}